ArticleLeukemia & lymphoma2023

Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab.

Rose Parisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.